1-how make the antibody, mouse then humanise, human ‘transgenic mice, phage libraries.
2-Mechanism of action- Direct killing, ADCC, CDC, neutralisation, drug or radiolabeled conjugate?
4-Specificity,how you will examine its specificity.
6-phace I clinical trial, how it will be preformed, then phaseII and phase III.
PLEASE make sure that it is a novel monoclonal antibody targeting a novel target.and make sure you cover all the
6 points i have mentioned, with all the tests and assays need to be done in the screening.
regarding the reference,i just need you to reference whatever needs to be referenced, so you can go for more or
less, the most important thing i need 1500 word in this essay at least,without the reference words